Inhibitors of signal transduction: The alkylphosphocholines

被引：0

作者：

Hilgard, F ^{[1
]}

Klenner, T ^{[1
]}

Engel, J ^{[1
]}

机构：

[1] ASTA Med AG, Expt Canc Res, D-60001 Frankfurt, Germany

来源：

DRUG NEWS & PERSPECTIVES | 1999年 / 12卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The experimental antitumor activity of the alkylphosphocholines, a new class of signal transduction inhibitors, has been demonstrated repeatedly. The alkylphosphocholines have inhibitory activities on protein kinase C (PKC) and phospholipase C. The PKC pathway of signal transduction may be involved in cellular differentiation and in the induction of apoptosis. Moreover, PKC inhibition by miltefosine may affect tumor invasion and metastasis formation. Miltefosine may also interfere with immunological mechanisms. Finally, in addition to its antitumor activity, miltefosine also exerts substantial effects on a number of Leishmania strains. In brief, miltefosine and other alkylphosphocholines interact with signal transduction components of cellular functions such as differentiation, growth control, migration, tumor promotion and cell death. Due to these activities, this new class of pharmacophores has a great potential in the treatment of cancer and certain parasitic diseases. (C) 1999 Prous Science. All rights reserved.

引用

页码：69 / 72

页数：4

共 50 条

[21] Resistance mechanisms against signal transduction inhibitors [J].

Pao, William .

ANNALS OF ONCOLOGY, 2006, 17 :45-45

[22] Signal transduction therapy of cancer with kinase inhibitors [J].

Keri, Gyorgy ;

Orfi, Laszlo ;

Greff, Zoltan ;

Pato, Janos ;

Szokol, Balint ;

Kekesi, Laszlo ;

Sipos, Anna ;

Garamvolgyi, Rita .

CURRENT OPINION IN BIOTECHNOLOGY, 2013, 24 :S20-S20

[23] Signal transduction inhibitors in chronic lymphocytic leukemia [J].

Ma, Shuo ;

Rosen, Steven T. .

CURRENT OPINION IN ONCOLOGY, 2011, 23 (06) :601-608

[24] Signal Transduction Inhibitors as Promising Anticancer Agents [J].

Kumar, Raj ;

Dos Santos, Cedric ;

Ahluwalia, Tarunveer Singh ;

Singh, Sandeep .

BIOMED RESEARCH INTERNATIONAL, 2015, 2015

[25] Phosphotyrosyl mimetics in the development of signal transduction inhibitors [J].

Burke, TR ;

Lee, K .

ACCOUNTS OF CHEMICAL RESEARCH, 2003, 36 (06) :426-433

[26] Signal transduction inhibitors in treatment of myelodysplastic syndromes [J].

Bachegowda, Lohith ;

Gligich, Oleg ;

Mantzaris, Ionnis ;

Schinke, Carolina ;

Wyville, Dale ;

Carrillo, Tatiana ;

Braunschweig, Ira ;

Steidl, Ulrich ;

Verma, Amit .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6

[27] Combining flavopiridol with various signal transduction inhibitors [J].

Witters, LM ;

Myers, A ;

Lipton, A .

ONCOLOGY REPORTS, 2004, 11 (03) :693-698

[28] Signal transduction inhibitors for the treatment of rheumatoid arthritis [J].

Tanaka, Yoshiya ;

Yamaoka, Kunihiro .

ARTHRITIS RESEARCH & THERAPY, 2012, 14

[29] Inhibitors of RAS signal transduction as antitumor agents [J].

Garbay, C ;

Liu, WQ ;

Vidal, M ;

Rogues, BP .

BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1165-1169

[30] Isolation, synthesis, and biological activities of signal transduction inhibitors [J].

Umezawa, Kazuo ;

Watanabe, Takumi .

Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry, 1996, 54 (12) :59-67

← 1 2 3 4 5 →